Test Compendium is your definitive resource for detailed information on a wide array of diagnostic tests. Each entry in our compendium is meticulously cataloged to aid healthcare providers in selecting and interpreting the right tests for their patients.
Displaying 301 - 325 of 475
Concurrent DeepSight™ Comprehensive 523 genes Liquid Biopsy (Somatic) + Neovare Portfolio testing (Germline) Methodology Molecular Test Description Disease Solid tumors; Breast cancer, Ovarian cancer,
Concurrent DeepSight™ on Liquid + siPortfolio Multi-Omics™ on Tissue Methodology Molecular Test Description Disease Solid tumorsOn Tissue: siPortfolio Multi-Omics™ • NGS (500+ genes, TMB, MSI)
LymphoSight™ Test Description Probes/Genes IHC/CISH ALK1, BCL-1, BCL-2, BCL-6, BRAF, Bob1, CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD15, CD20, CD21, CD23, CD25*, CD30, CD43, CD79a, CD138, C-MYC, EBV-LMP, Granzyme B, ICOS*, IgA, IgG, IgG4, IgM, Kappa, Ki-67, Lambda, LEF1*, Mum1, OCT2, Pax5, Perforin, PD-1, TIA1. *: Pending CISH: EBER, Kappa,
CA19.9 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CA199 IHC Disease Pancreatic Cancer, colorectal cancerCA-19-9, also called cancer antigen-19-9 or sialylated Lewis (a) antigen,
Caldesmon Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CALDES IHC Disease Smooth Muscle TumorsCaldesmon is a protein that in humans is encoded by the CALD1 gene. It is a smooth
Calponin Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CALPON IHC Disease Tumors of smooth muscle or myoepithelial lineage,(especially urogenital tract), infiltrating breast carcinoma.Basic
Calretinin Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CALRET IHC Disease mesothelioma, adrenocortical tumors.Calretinin is a calcium-binding protein originally found in neurons.
CAM5.2 (CK8/18/19) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CAM5 IHC Disease Epithelial cells tumorsAnti-Cytokeratin (CAM 5.2) has a primary reactivity with human keratin proteins
CD10 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD10 IHC Disease Lymphoma (lymphoblastic, Burkitt's and follicular lymphomas.), endometrial stromal sarcoma.CD10 antigen, Also
CD103 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD103 IHC Disease Lymphoma (hairy cell leukemia, enteropathy associated T-cell lymphoma, and some splenic marginal zone lymphomas.)CD103
CD117 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD117 IHC Disease Gastrointestinal Stromal Tumors (GISTs), mast cell diseases, acute myeloid leukemia (AML), small cell lung carcinoma
CD117(C-KIT) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD117 (C-KIT) IHC Disease Gastrointestinal Stromal Tumors (GISTs), mast cell diseases, acute myeloid leukemia (AML), small
CD138 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD138 IHC Disease Plasma Cell Dyscrasia, primary effusion lymphoma.CD138 molecule is a transmembrane heparan sulphate glycoprotein
CD15 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD15 IHC Disease Hodgkin's LymphomaCD15 antigen, also known as X-hapten, is reported to be expressed on 90% of circulating human
CD163 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD163 IHC Disease Hodgkin's lymphoma, Histiocytic Sarcoma, Non-Langerhans-Cell Histiocytosis.The protein encoded by this gene
CD1a Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD1A IHC Disease Cutaneous T-cell lymphomas, Langerhans cell histiocytosis.CD1a is expressed on dendritic cells and cortical thymocytes.
CD2 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD2 IHC Disease T-cell Lymphomas, NK cell malignancies, colorectal cancer, urethelial cancer, breast cancer, prostate cancer, lung
CD20 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD20 IHC Disease Lymphoma (B-cell lymphomas: B-ALL/B-LBL, lymphocyte predominant Hodgkin lymphoma, spindle cell thymomas)B-lymphocyte
CD21 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD21 IHC Disease Follicular, mantle cell lymphomas, and mature leukemiasCD21 antigen is a type I integral membrane glycoprotein
CD23 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD23 IHC Disease Lymphomas, and B-cell chronic lymphomocytic leukaemiasCD23 can be demonstrated in germinal centre follicular dendritic
CD3 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD3 IHC Disease T-cell lymphomas and leukaemiasCD3 is a protein complex and T cell co-receptor that is involved in activating both
CD30(Ki-1) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD30 IHC Disease Immunoblastic B cell or anaplastic T cell malignant lymphomasCD30, also known as TNFRSF8, is a cell membrane
CD31 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD31 IHC Disease Angiomas, angiosarcomas, and small lymphocytic and lymphoblastic lymphomasCD31 is a transmembrane protein encoded
CD34 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD34 IHC Disease Acute myeloid leukemia (AML), Acute lymphoblastic leukemia (ALL), Gastrointestinal stromal tumor (GIST), dermatofibrosarcoma
CD35 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD35 IHC Disease Follicular dendritic cell tumor/sarcoma, and MALTomaCD35, complement receptor 1, is a cell membrane-bound, monomeric
CD4 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD4 IHC Disease T CELL neoplasmsCD4 is a co-receptor of the T cell receptor (TCR) and assists the latter in communicating with antigen-presenting
CD43 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD43 IHC Disease Pan T cell marker Classify subtypes of T cell lymphomas and low grade B cell lymphomas Differentiate
CD45(LCA) Alternative Name Leukocyte Common Antigen (LCA) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD45 IHC Disease Confirm the hematopoietic nature of tumors. Highlight
With core values rooted in service and integrity, our leadership team sets the bar high.
We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.
siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).
We also hold select state licensure where required.